Background: Chronic kidney disease (CKD) patients do not have the ability to monitor azotemia via an at-home test. To address this, we have developed a simple method for measuring breath NH3 and conducted a clinical trial with CKD patients (stages 1, 3, 5) with comparison to blood urea nitrogen (BUN) as a potential at-home method for monitoring kidney function. Methods: The device includes a mouthpiece, pressure gauge to monitor flow rate, color-indicating disc, and breath collection bag (1-L Tedlar bag) to control exhaled breath volume (Fig. 1). The color response is read using a MatLab program to quantify the color using an RGB scale. Calibration was conducted in the lab using simulated exhaled breath (5% CO2 in humidified air with NH3 ranged from 0 - 10,000 ppb). The clinical trial was conducted with 10 CKD patients, including a patient immediately before and after hemodialysis. Patients exhaled through the device at a designated pressure gauge reading until the Tedlar bag was full (< 1 min), with the test done in triplicate. The color change was then read and the ppb of NH3 determined using the calibration plot and plotted against the patient's BUN level.Fig. 1Results: High correlation was found between breath NH3 and BUN level (Fig. 2), with significantly different values in breath NH3 between stages 1-5 and 3-5, but not between stages 1-3. Results for the patient undergoing hemodialysis showed 58 mg/dL (BUN) and 5,400 +/- 1,400 ppb (breath NH3) before hemodialysis and 11 mg/dL (BUN) and 300 +/- 100 ppb (breath NH3) after hemodialysis.Fig. 2Conclusions: These results indicate that the developed test has potential as a simple at-home method for patients to monitor their CKD condition, especially in advanced CKD.